Sandu Pharmaceuticals standalone net profit rises 33.33% in the September 2022 quarter
Sales decline 4.72% to Rs 16.76 crore
Net profit of Sandu Pharmaceuticals rose 33.33% to Rs 0.60 crore in the quarter ended September 2022 as against Rs 0.45 crore during the previous quarter ended September 2021. Sales declined 4.72% to Rs 16.76 crore in the quarter ended September 2022 as against Rs 17.59 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales16.7617.59 -5 OPM %5.134.55 -PBDT1.010.78 29 PBT0.880.65 35 NP0.600.45 33Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 15 2022 | 2:49 PM IST